NCT04047706 2025-06-29
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Northwestern University
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT03192943 2019-04-01
A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors
Bristol-Myers Squibb
Phase 1 Completed
NCT03312426 2018-01-19
An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants
Bristol-Myers Squibb
Phase 1 Completed
NCT03247283 2017-11-06
Pharmacokinetics and Metabolism Study in Healthy Male Participants
Bristol-Myers Squibb
Phase 1 Completed